CANMAB 150mg Injection is a targeted therapy used primarily in the treatment of HER2-positive breast cancer and gastric cancer. It contains Trastuzumab, a monoclonal antibody that specifically targets the HER2 protein, helping slow or stop the growth of cancer cells.
Key Uses of CANMAB 150mg Injection
HER2-Positive Breast Cancer: Used for early-stage and metastatic breast cancer in combination with chemotherapy.
HER2-Positive Gastric Cancer: Helps slow tumor growth in advanced gastric cancers.
How CANMAB 150mg Works
CANMAB 150mg targets the HER2 (human epidermal growth factor receptor 2) protein, which promotes cancer cell growth. By blocking HER2, it:
Slows cancer cell multiplication
Enhances the immune system’s ability to fight cancer
Improves treatment effectiveness when combined with chemotherapy
Dosage Administration
Administered by a healthcare professional via intravenous (IV) infusion.
Typical dosage: The doctor determines the dosage based on the patient’s weight and treatment plan.
Given every 1 to 3 weeks, depending on treatment protocol.
Potential Side Effects
Common Side Effects:
- Fever chills
- Nausea vomiting
- Fatigue
- Diarrhea
- Headache
Serious Side Effects (Seek Medical Help):
- Heart complications (shortness of breath, swelling)
- Severe allergic reactions
- Liver or kidney issues
Who Should Avoid CANMAB 150mg?
Individuals with:
- Heart disease or a history of heart failure
- Allergies to Trastuzumab
- Severe lung conditions
Pregnant or breastfeeding women should consult a doctor before use.
Final Thoughts
CANMAB 150mg Injection is a game-changer in cancer treatment, significantly improving survival rates in HER2-positive cancer patients. However, it should only be taken under strict medical supervision to monitor side effects and effectiveness.
